» Articles » PMID: 34944325

Pharmacokinetic Profile of Fentanyl in the Koala () After Intravenous Administration, and Absorption Via a Transdermal Patch

Overview
Journal Animals (Basel)
Date 2021 Dec 24
PMID 34944325
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Fentanyl was administered as a single intravenous bolus injection at 5 µg/kg to five koalas and fentanyl plasma concentrations for a minimum of 2 h were quantified by an enzyme-linked immunosorbent assay (ELISA). The median (range) fentanyl elimination half-life and clearance were 0.53 (0.38-0.91) h, and 10.01 (7.03-11.69) L/kg/h, respectively. Assuming an analgesic therapeutic plasma concentration of 0.23 ng/mL (extrapolated from human studies), an intravenous constant infusion rate was estimated at approximately between 1.7 to 2.7 µg/kg/h (using the clearance 95% confidence intervals). A transdermal fentanyl patch was applied to the antebrachium of an additional two koalas for 72 h. Fentanyl plasma concentrations were determined during the patch application and after patch removal at 80 h. The fentanyl plasma concentration was greater than 0.23 ng/mL after 12 to 16 h. While the patch was applied, the maximum fentanyl concentration was approximately 0.7 ng/mL from 32 to 72 h. Fentanyl plasma concentrations increased to 0.89 ng/mL 1 h after the patch was removed, and then decreased to a mean of 0.47 ng/mL at 80 h. The transdermal fentanyl patch is likely to provide some level of analgesia but should be initially co-administered with another faster acting analgesic for the first 12 h.

Citing Articles

Pharmacokinetic profile of oral and subcutaneous administration of paracetamol in the koala (Phascolarctos cinereus) and prediction of its analgesic efficacy.

Govendir M, Vogelnest L, Shapiro A, Marschner C, Kimble B PLoS One. 2024; 19(4):e0300703.

PMID: 38630750 PMC: 11023281. DOI: 10.1371/journal.pone.0300703.


Effect of Transdermal Fentanyl Patch Combined with Enhanced Recovery after Surgery on the Curative Effect and Analgesic Effect of Liver Cancer.

Zhu H, Xiao H, Lu G, Fang S Biomed Res Int. 2022; 2022:9722458.

PMID: 35924273 PMC: 9343188. DOI: 10.1155/2022/9722458.


Health and Diseases of Koalas.

Speight N Animals (Basel). 2022; 12(8).

PMID: 35454251 PMC: 9027410. DOI: 10.3390/ani12081005.


Pharmacokinetic Profile of Doxycycline in Koala Plasma after Weekly Subcutaneous Injections for the Treatment of Chlamydiosis.

Chen C, Gillett A, Booth R, Kimble B, Govendir M Animals (Basel). 2022; 12(3).

PMID: 35158574 PMC: 8833767. DOI: 10.3390/ani12030250.

References
1.
Mills P, Cross S . Regional differences in the in vitro penetration of methylsalicylate through equine skin. Vet J. 2005; 173(1):57-61. DOI: 10.1016/j.tvjl.2005.08.023. View

2.
Egger C, Glerum L, Allen S, Haag M . Plasma fentanyl concentrations in awake cats and cats undergoing anesthesia and ovariohysterectomy using transdermal administration. Vet Anaesth Analg. 2003; 30(4):229-36. DOI: 10.1046/j.1467-2995.2003.00109.x. View

3.
Whittem T, Pasloske K, Heit M, Ranasinghe M . The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. J Vet Pharmacol Ther. 2008; 31(6):571-9. DOI: 10.1111/j.1365-2885.2008.00998.x. View

4.
Lovasz M, Aarnes T, Hubbell J, Bednarski R, Lerche P, Lakritz J . Pharmacokinetics of intravenous and transdermal fentanyl in alpacas. J Vet Pharmacol Ther. 2017; 40(6):663-669. DOI: 10.1111/jvp.12403. View

5.
Pypendop B, Brosnan R, Majewski-Tiedeken C, Stanley S, Ilkiw J . Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats. J Vet Pharmacol Ther. 2013; 37(1):13-7. DOI: 10.1111/jvp.12047. View